Coya Therapeutics
COYA
19 hedge funds and large institutions have $33.1M invested in Coya Therapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
60% more capital invested
Capital invested by funds: $20.6M → $33.1M (+$12.5M)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
5.17% less ownership
Funds ownership: 28.14% → 22.96% (-5.2%)
10% less funds holding
Funds holding: 21 → 19 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.88M |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$863K |
| 3 |
State Street
Boston,
Massachusetts
|
+$362K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$263K |
| 5 |
BlackRock
New York
|
+$252K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$3M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$687K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$123K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$24.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14.7K |
COYA Hedge Fund Activity: Q1 2024 in Review
19 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q1 2024, worth a combined $33.1M — up 60% from $20.6M a quarter earlier.
Fund positioning in COYA was balanced in Q1 2024: 4 funds opened new positions, 4 closed out, 9 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $5.88M. The largest seller was AIGH Capital Management, cutting an estimated $3M.
- 19 institutional investors held Coya Therapeutics (COYA) as of Q1 2024, down from 21 in Q4 2023.
- Funds reported $33.1M of Coya Therapeutics stock for Q1 2024, up 60% quarter-over-quarter.
- 4 funds opened new Coya Therapeutics positions in Q1 2024 and 4 closed out, a net change of 0 holders.
- The largest Coya Therapeutics buyer in Q1 2024 was Vanguard Group, an estimated $5.88M added.
- The largest Coya Therapeutics seller in Q1 2024 was AIGH Capital Management, an estimated $3M sold.
Based on aggregated 13F filings for Q1 2024.